C
SGMO

Covestor’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Covestor’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-46
Closed – – 2414
2021
Q4 		$0 Buy
+46
New +$400 ﹤0.01% 2287

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Covestor's SGMO Position: Q1 2022 in Review

Covestor sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2022, closing a stake of 46 shares.

Covestor first reported a position in SGMO in Q4 2021 and held it in 1 quarter. The position peaked at $0 in Q4 2021. 195 funds tracked by Wall St. Rank hold SGMO as of Q1 2022.

  • Covestor reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2022 after selling out during the quarter.
  • Covestor sold 46 SANGAMO THERAPEUTICS INC shares in Q1 2022.
  • Covestor first reported a position in SANGAMO THERAPEUTICS INC in Q4 2021 and held it in 1 quarter.
  • Covestor's SANGAMO THERAPEUTICS INC position peaked at $0 in Q4 2021.
  • 195 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2022.

Based on Covestor's 13F filing for Q1 2022, filed 13 May 2022.